Paper17533201
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.
Abdel-Latif A and 8 others. Arch Intern Med, 2007. Cited by 687 papers, by iCite.
Cite this record
ConductScience Library. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Papers, record 17533201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17533201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Myocardial Ischemia | Major topic |
| Bone Marrow Cells | |
| Humans | |
| Meta-Analysis as Topic | |
| Myocardial Infarction | |
| Randomized Controlled Trials as Topic | |
| Treatment Outcome | |
| Ventricular Function |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HL-55757 | NHLBI NIH HHS | United States | R01HL055757 | PubMed and NIH | NIH RePORTER |
| HL-68088 | NHLBI NIH HHS | United States | R01HL068088 | PubMed and NIH | NIH RePORTER |
| HL-70897 | NHLBI NIH HHS | United States | R01HL070897 | PubMed and NIH | NIH RePORTER |
| HL-76794 | NHLBI NIH HHS | United States | R01HL076794 | PubMed and NIH | NIH RePORTER |
| HL-78825 | NHLBI NIH HHS | United States | P01HL078825 | PubMed and NIH | NIH RePORTER |
| R01 HL-72410 | NHLBI NIH HHS | United States | R01HL072410 | PubMed and NIH | NIH RePORTER |
| R37HL055757 | NIH | NIH RePORTER |
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00725738 | Intracoronary Autologous Stem Cell Transplantation in ST Elevation Myocardial Infarction: TRACIA STUDY. | Background | ClinicalTrials.gov | |
| NCT01214499 | Prospective, Controlled and Randomized Clinical Trial on Cardiac Cell Regeneration With Laser and Autologous Bone Marrow Stem Cells, in Patients With Coronary Disease and Refractory Angina | Background | ClinicalTrials.gov | |
| NCT01660581 | Intracardiac CD133+ Cells in Patients With No-option Resistant Angina | Background | ClinicalTrials.gov | |
| NCT04893629 | New Horizons for the Treatment of Cardiomyopathy in Children | Background | ClinicalTrials.gov |
Cited by317
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 687 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41751823 | Characterization, Preconditioning, Safety, and Other Issues of MSC-Derived EVs and Secretome. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751823 | PubMed |
| 40159511 | Preclinical extracellular matrix-based treatment strategies for myocardial infarction: a systematic review and meta-analysis. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/40159511 | PubMed |
| 39762890 | NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K/ Akt/mTOR pathway in diabetic myocardial infarction. | Cardiovasc Diabetol | 2025 | https://conductscience.org/library/papers/39762890 | PubMed |
| 39076280 | Healing the Ischaemic Heart: A Critical Review of Stem Cell Therapies. | Rev Cardiovasc Med | 2023 | https://conductscience.org/library/papers/39076280 | PubMed |
| 37900276 | Regenerative potential of mesenchymal stromal cells in wound healing: unveiling the influence of normoxic and hypoxic environments. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37900276 | PubMed |
| 36514148 | Stem cell laden nano and micro collagen/PLGA bimodal fibrous patches for myocardial regeneration. | Biomater Res | 2022 | https://conductscience.org/library/papers/36514148 | PubMed |
| 35626749 | Mitochondrial Membrane Potential Identifies a Subpopulation of Mesenchymal Progenitor Cells to Promote Angiogenesis and Myocardial Repair. | Cells | 2022 | https://conductscience.org/library/papers/35626749 | PubMed |
| 35231426 | Heart regeneration: 20 years of progress and renewed optimism. | Dev Cell | 2022 | https://conductscience.org/library/papers/35231426 | PubMed |
| 34986181 | Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis. | PLoS One | 2022 | https://conductscience.org/library/papers/34986181 | PubMed |
| 34122557 | The Application Potential and Advance of Mesenchymal Stem Cell-Derived Exosomes in Myocardial Infarction. | Stem Cells Int | 2021 | https://conductscience.org/library/papers/34122557 | PubMed |
| 33805763 | Cardiac Cell Therapy for Heart Repair: Should the Cells Be Left Out? | Cells | 2021 | https://conductscience.org/library/papers/33805763 | PubMed |
| 33803227 | Stem Cells in Cardiovascular Diseases: 30,000-Foot View. | Cells | 2021 | https://conductscience.org/library/papers/33803227 | PubMed |
| 33060956 | Transmyocardial revascularization (TMR): current status and future directions. | Indian J Thorac Cardiovasc Surg | 2018 | https://conductscience.org/library/papers/33060956 | PubMed |
| 32545336 | Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice. | Biomedicines | 2020 | https://conductscience.org/library/papers/32545336 | PubMed |
| 31772589 | Combining ECM Hydrogels of Cardiac Bioactivity with Stem Cells of High Cardiomyogenic Potential for Myocardial Repair. | Stem Cells Int | 2019 | https://conductscience.org/library/papers/31772589 | PubMed |
| 31438858 | Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol. | BMC Cardiovasc Disord | 2019 | https://conductscience.org/library/papers/31438858 | PubMed |
| 31381876 | Efficacy of stem cell-based therapies for stroke. | Brain Res | 2019 | https://conductscience.org/library/papers/31381876 | PubMed |
| 31257465 | Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on erectile dysfunction in diabetic rats. | Int J Mol Med | 2019 | https://conductscience.org/library/papers/31257465 | PubMed |
| 30808255 | Lipopolysaccharides Improve Mesenchymal Stem Cell-Mediated Cardioprotection by MyD88 and stat3 Signaling in a Mouse Model of Cardiac Ischemia/Reperfusion Injury. | Stem Cells Dev | 2019 | https://conductscience.org/library/papers/30808255 | PubMed |
| 30763348 | Treatment with mononuclear cell populations improves post-infarction cardiac function but does not reduce arrhythmia susceptibility. | PLoS One | 2019 | https://conductscience.org/library/papers/30763348 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17533201
GET https://conductscience.org/api/papers/v1/17533201/cited_by?page=2